|
All-Trans Retinoic Acid (ATRA) Dose -1 Clinical Trials
1 actively recruiting trial across 1 location
Houston, Texas1 trial
ATRA and Carfilzomib in Plasma Cell Myeloma Patients
Houston Methodist Neal Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.